Clinical Trial Update: Pathways, Risk Factors, and mOleculeS to Prevent Early-onset Colorectal Tumors [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial sponsored by Massachusetts General Hospital is investigating pathways, risk factors, and molecules to prevent early-onset colorectal tu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Adenoma
• Colorectal Cancer

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Colorectal Cancer Prevention, Colorectal Adenoma | Phase 1 | Status: RECRUITING